vs
Ecovyst Inc.（ECVT）与Tarsus Pharmaceuticals, Inc.（TARS）财务数据对比。点击上方公司名可切换其他公司
Ecovyst Inc.的季度营收约是Tarsus Pharmaceuticals, Inc.的1.3倍（$199.4M vs $151.7M），Tarsus Pharmaceuticals, Inc.同比增速更快（128.4% vs 34.0%），Ecovyst Inc.自由现金流更多（$22.9M vs $13.0M），过去两年Tarsus Pharmaceuticals, Inc.的营收复合增速更高（134.4% vs 18.7%）
Ecovyst Inc.是一家全球可持续特种材料供应商，主营高性能催化剂与功能性添加剂的研发、生产，产品服务覆盖工业制造、消费品、环保等核心领域，助力全球客户提升运营效率、降低碳排放。
Tarsus Pharmaceuticals是一家处于后期临床阶段的生物制药公司，专注于眼科、皮肤科等专科领域创新疗法的研发和商业化，主打产品针对蠕形螨睑缘炎、玫瑰痤疮等未被充分诊断的常见病症，核心市场为美国。
ECVT vs TARS — 直观对比
营收规模更大
ECVT
是对方的1.3倍
$151.7M
营收增速更快
TARS
高出94.4%
34.0%
自由现金流更多
ECVT
多$10.0M
$13.0M
两年增速更快
TARS
近两年复合增速
18.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $199.4M | $151.7M |
| 净利润 | — | $-8.4M |
| 毛利率 | 23.4% | — |
| 营业利润率 | 10.9% | -5.3% |
| 净利率 | — | -5.5% |
| 营收同比 | 34.0% | 128.4% |
| 净利润同比 | — | 63.8% |
| 每股收益（稀释后） | $0.06 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ECVTTARS
| Q4 25 | $199.4M | $151.7M | ||
| Q3 25 | $204.9M | $118.7M | ||
| Q2 25 | $176.1M | $102.7M | ||
| Q1 25 | $143.1M | $78.3M | ||
| Q4 24 | $148.9M | $66.4M | ||
| Q3 24 | $153.9M | $48.1M | ||
| Q2 24 | $154.0M | $40.8M | ||
| Q1 24 | $141.6M | $27.6M |
净利润ECVTTARS
| Q4 25 | — | $-8.4M | ||
| Q3 25 | $-79.3M | $-12.6M | ||
| Q2 25 | $6.0M | $-20.3M | ||
| Q1 25 | $-3.6M | $-25.1M | ||
| Q4 24 | — | $-23.1M | ||
| Q3 24 | $14.3M | $-23.4M | ||
| Q2 24 | $8.3M | $-33.3M | ||
| Q1 24 | $1.2M | $-35.7M |
毛利率ECVTTARS
| Q4 25 | 23.4% | — | ||
| Q3 25 | 25.4% | — | ||
| Q2 25 | 22.8% | — | ||
| Q1 25 | 13.3% | — | ||
| Q4 24 | 28.9% | — | ||
| Q3 24 | 29.3% | — | ||
| Q2 24 | 27.3% | — | ||
| Q1 24 | 23.5% | — |
营业利润率ECVTTARS
| Q4 25 | 10.9% | -5.3% | ||
| Q3 25 | 13.8% | -12.2% | ||
| Q2 25 | 9.0% | -21.6% | ||
| Q1 25 | -0.7% | -33.5% | ||
| Q4 24 | 15.1% | -36.8% | ||
| Q3 24 | 17.9% | -52.3% | ||
| Q2 24 | 14.1% | -81.6% | ||
| Q1 24 | 9.5% | -136.5% |
净利率ECVTTARS
| Q4 25 | — | -5.5% | ||
| Q3 25 | -38.7% | -10.6% | ||
| Q2 25 | 3.4% | -19.8% | ||
| Q1 25 | -2.5% | -32.1% | ||
| Q4 24 | — | -34.8% | ||
| Q3 24 | 9.3% | -48.7% | ||
| Q2 24 | 5.4% | -81.6% | ||
| Q1 24 | 0.9% | -129.4% |
每股收益（稀释后）ECVTTARS
| Q4 25 | $0.06 | $-0.17 | ||
| Q3 25 | $-0.69 | $-0.30 | ||
| Q2 25 | $0.05 | $-0.48 | ||
| Q1 25 | $-0.03 | $-0.64 | ||
| Q4 24 | $-0.26 | $-0.57 | ||
| Q3 24 | $0.12 | $-0.61 | ||
| Q2 24 | $0.07 | $-0.88 | ||
| Q1 24 | $0.01 | $-1.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $197.2M | $417.3M |
| 总债务越低越好 | $392.6M | $72.4M |
| 股东权益账面价值 | $603.4M | $343.4M |
| 总资产 | $1.3B | $562.2M |
| 负债/权益比越低杠杆越低 | 0.65× | 0.21× |
8季度趋势，按日历期对齐
现金及短期投资ECVTTARS
| Q4 25 | $197.2M | $417.3M | ||
| Q3 25 | $82.0M | $401.8M | ||
| Q2 25 | $69.6M | $381.1M | ||
| Q1 25 | $127.5M | $407.9M | ||
| Q4 24 | $131.4M | $291.4M | ||
| Q3 24 | $123.5M | $317.0M | ||
| Q2 24 | $83.3M | $323.6M | ||
| Q1 24 | $103.1M | $298.5M |
总债务ECVTTARS
| Q4 25 | $392.6M | $72.4M | ||
| Q3 25 | $854.8M | $72.3M | ||
| Q2 25 | $856.6M | $72.1M | ||
| Q1 25 | $859.0M | $72.0M | ||
| Q4 24 | $860.8M | $71.8M | ||
| Q3 24 | $862.7M | $71.7M | ||
| Q2 24 | $862.4M | $71.6M | ||
| Q1 24 | $866.2M | $29.9M |
股东权益ECVTTARS
| Q4 25 | $603.4M | $343.4M | ||
| Q3 25 | $607.9M | $335.1M | ||
| Q2 25 | $692.4M | $332.6M | ||
| Q1 25 | $698.7M | $342.5M | ||
| Q4 24 | $700.5M | $224.5M | ||
| Q3 24 | $729.4M | $237.5M | ||
| Q2 24 | $717.3M | $252.2M | ||
| Q1 24 | $711.4M | $275.2M |
总资产ECVTTARS
| Q4 25 | $1.3B | $562.2M | ||
| Q3 25 | $1.7B | $534.6M | ||
| Q2 25 | $1.8B | $495.0M | ||
| Q1 25 | $1.8B | $500.8M | ||
| Q4 24 | $1.8B | $377.0M | ||
| Q3 24 | $1.8B | $376.3M | ||
| Q2 24 | $1.8B | $376.8M | ||
| Q1 24 | $1.8B | $349.3M |
负债/权益比ECVTTARS
| Q4 25 | 0.65× | 0.21× | ||
| Q3 25 | 1.41× | 0.22× | ||
| Q2 25 | 1.24× | 0.22× | ||
| Q1 25 | 1.23× | 0.21× | ||
| Q4 24 | 1.23× | 0.32× | ||
| Q3 24 | 1.18× | 0.30× | ||
| Q2 24 | 1.20× | 0.28× | ||
| Q1 24 | 1.22× | 0.11× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $41.8M | $19.3M |
| 自由现金流经营现金流 - 资本支出 | $22.9M | $13.0M |
| 自由现金流率自由现金流/营收 | 11.5% | 8.6% |
| 资本支出强度资本支出/营收 | 9.4% | 4.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $69.9M | $-22.3M |
8季度趋势，按日历期对齐
经营现金流ECVTTARS
| Q4 25 | $41.8M | $19.3M | ||
| Q3 25 | $55.3M | $18.3M | ||
| Q2 25 | $33.0M | $-29.4M | ||
| Q1 25 | $10.3M | $-20.7M | ||
| Q4 24 | $43.5M | $-22.2M | ||
| Q3 24 | $59.9M | $-8.7M | ||
| Q2 24 | $10.0M | $-14.4M | ||
| Q1 24 | $36.5M | $-37.8M |
自由现金流ECVTTARS
| Q4 25 | $22.9M | $13.0M | ||
| Q3 25 | $53.2M | $16.3M | ||
| Q2 25 | $7.8M | $-30.4M | ||
| Q1 25 | $-14.0M | $-21.2M | ||
| Q4 24 | $30.9M | $-22.3M | ||
| Q3 24 | $53.6M | $-8.9M | ||
| Q2 24 | $-9.3M | $-15.4M | ||
| Q1 24 | $19.1M | $-38.0M |
自由现金流率ECVTTARS
| Q4 25 | 11.5% | 8.6% | ||
| Q3 25 | 26.0% | 13.8% | ||
| Q2 25 | 4.4% | -29.6% | ||
| Q1 25 | -9.8% | -27.1% | ||
| Q4 24 | 20.7% | -33.5% | ||
| Q3 24 | 34.9% | -18.6% | ||
| Q2 24 | -6.1% | -37.8% | ||
| Q1 24 | 13.5% | -137.5% |
资本支出强度ECVTTARS
| Q4 25 | 9.4% | 4.2% | ||
| Q3 25 | 1.0% | 1.6% | ||
| Q2 25 | 14.4% | 1.0% | ||
| Q1 25 | 16.9% | 0.8% | ||
| Q4 24 | 8.5% | 0.1% | ||
| Q3 24 | 4.1% | 0.6% | ||
| Q2 24 | 12.5% | 2.5% | ||
| Q1 24 | 12.3% | 0.6% |
现金转化率ECVTTARS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 5.52× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 4.21× | — | ||
| Q2 24 | 1.20× | — | ||
| Q1 24 | 29.90× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ECVT
| Industrial Mining Automotive | $101.3M | 51% |
| Regeneration And Treatment Services | $90.0M | 45% |
| Other | $8.1M | 4% |
TARS
暂无分部数据
